Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.

Acta dermato-venereologica - 1 Jan 2010

Antunes Joana, Filipe Paulo, André Marisa, Fraga Ana, Miltenyi Gabriel, Marques Gomes Manuel

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Therapy, Combination
Share to Fibrinolytic Agents
Share to Homozygote

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Plasminogen Activator Inhibitor 1

Share to Prothrombin

Share to Tissue Plasminogen Activator

Share to Treatment Outcome

Source

Identifiers

PMID: 20107738
DOI: 10.2340/00015555-0760

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) and prothrombin G20210A heterozygosity: response to t-PA therapy.PMID 20107738Read ↗

Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.Semantic proximity Read ↗

Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis.Semantic proximity Read ↗

Livedoid vasculopathy and its association with genetic variants: A systematic review.Semantic proximity Read ↗

TTP or complement-mediated TMA or both? A rare diagnosis and report of a novel plasminogen gene variant.Semantic proximity Read ↗

Livedo vasculopathy associated with methylenetetrahydrofolate reductase C677T homozygosity.Semantic proximity Read ↗

Leg ulcers revealing familial thrombophilia: prothrombin G20210A gene mutation and plasminogen activator inhibitor type 1 (PAI-1) polymorphism.Semantic proximity Read ↗

Sickle cell vasculopathy: vascular phenotype on fire!Semantic proximity Read ↗

Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies.Semantic proximity Read ↗

Livedoid vasculopathy: thrombotic or inflammatory disease?Semantic proximity Read ↗

A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency.Semantic proximity Read ↗

Adult-onset arterial thrombosis in a pedigree of homozygous and heterozygous protein C deficiency.Semantic proximity Read ↗

Homozygous G20210A prothrombin gene mutation without thromboembolic events: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.